Trial Profile
Inflammation after photodynamic therapy of actinic keratoses
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2016
Price :
$35
*
At a glance
- Drugs Clobetasol (Primary) ; Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 13 Dec 2016 New trial record